Professor, Biocomplexity Institute
Dr. Josep Bassaganya-Riera is a professor at the Biocomplexity Institute of Virginia Tech., an entrepreneur and investor. He is the scientific founder of BioTherapeutics, a biotech Company that develops oral therapeutics for autoimmune diseases and diabetes (www.biotherapeuticsinc.com). Dr. Bassaganya-Riera directs the Nutritional Immunology and Molecular Medicine Laboratory at Virginia Tech (www.nimml.org) where he employs computational and mathematical models of the gut immune system in combination with preclinical and clinical experimentation to gain mechanistic insights about the gut immune system and to develop new therapeutics for gastrointestinal diseases. He has over 17 years of preclinical, mechanistic and translational research experience in immune-mediated, infectious and inflammatory diseases, published over 120 peer-reviewed papers, 15 patents and has secured over $18 million in funding from NIH grants and contracts, industrial partners, and equity financing.